5 ms·
> It expects to save $1,356.35 per pneumonia patient in direct variable costs (35 percent savings) versus the status quo, while reducing length of stay by two d
by ballenf 8y ago
> It expects to save $1,356.35 per pneumonia patient in direct variable costs (35 percent savings) versus the status quo, while reducing length of stay by two days. The new sepsis pathway has also been deployed.
So the headline was BS. This is the projected savings estimate used by the vendor, who totally coincidentally got a bump in their contract from 4 case studies a year to 12 on the basis of this totally objective guess.